Verrica Pharmaceuticals

VRCA

5.2601.54% ( +0.080 )

Closed: Jul 30, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Verrica Pharmaceuticals(VRCA) predict that the Revenue is 5.023 M (+46.06%), Beat estimate;the EBIT is -9.715 M (-19.5%), Miss estimate;the EPS is -0.45 (+55%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.01B46.06%

0.00B31.43%

+0.00B14.63%

EBITMiss expectations

-0.01B19.50%

-0.01B4.92%

-0.00B24.42%

EPSMiss expectations

-0.4555.00%

-0.4258.00%

-0.03003.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD